111 related articles for article (PubMed ID: 2682137)
21. Metabolic effects of troglitazone on fat-induced insulin resistance in the rat.
Khoursheed M; Miles PD; Gao KM; Lee MK; Moossa AR; Olefsky JM
Metabolism; 1995 Nov; 44(11):1489-94. PubMed ID: 7476339
[TBL] [Abstract][Full Text] [Related]
22. Reduction of insulin resistance in obese and/or diabetic animals by 5-[4-(1-methylcyclohexylmethoxy)benzyl]-thiazolidine-2,4-dione (ADD-3878, U-63,287, ciglitazone), a new antidiabetic agent.
Fujita T; Sugiyama Y; Taketomi S; Sohda T; Kawamatsu Y; Iwatsuka H; Suzuoki Z
Diabetes; 1983 Sep; 32(9):804-10. PubMed ID: 6354788
[TBL] [Abstract][Full Text] [Related]
23. Amelioration of high-fat feeding-induced insulin resistance in skeletal muscle with the antiglucocorticoid RU486.
Kusunoki M; Cooney GJ; Hara T; Storlien LH
Diabetes; 1995 Jun; 44(6):718-20. PubMed ID: 7789638
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the extrapancreatic action of BRX-220 and pioglitazone in the high-fat diet-induced insulin resistance.
Seböková E; Kürthy M; Mogyorosi T; Nagy K; Demcáková E; Ukropec J; Koranyi L; Klimes I
Ann N Y Acad Sci; 2002 Jun; 967():424-30. PubMed ID: 12079870
[TBL] [Abstract][Full Text] [Related]
25. Increased efficiency of fatty acid uptake contributes to lipid accumulation in skeletal muscle of high fat-fed insulin-resistant rats.
Hegarty BD; Cooney GJ; Kraegen EW; Furler SM
Diabetes; 2002 May; 51(5):1477-84. PubMed ID: 11978645
[TBL] [Abstract][Full Text] [Related]
26. Metabolic impairment precedes insulin resistance in skeletal muscle during high-fat feeding in rats.
Kim JK; Wi JK; Youn JH
Diabetes; 1996 May; 45(5):651-8. PubMed ID: 8621018
[TBL] [Abstract][Full Text] [Related]
27. Effect of troglitazone on vascular and glucose metabolic actions of insulin in high-sucrose-fed rats.
Santuré M; Pitre M; Nadeau A; Bachelard H
Metabolism; 2003 Aug; 52(8):978-86. PubMed ID: 12898461
[TBL] [Abstract][Full Text] [Related]
28. Insulin resistance of muscle glucose transport in rats fed a high-fat diet: a reevaluation.
Han DH; Hansen PA; Host HH; Holloszy JO
Diabetes; 1997 Nov; 46(11):1761-7. PubMed ID: 9356023
[TBL] [Abstract][Full Text] [Related]
29. Dose-response curves for in vivo insulin sensitivity in individual tissues in rats.
Kraegen EW; James DE; Jenkins AB; Chisholm DJ
Am J Physiol; 1985 Mar; 248(3 Pt 1):E353-62. PubMed ID: 3883806
[TBL] [Abstract][Full Text] [Related]
30. Ciglitazone, a new hypoglycemic agent. II. Effect on glucose and lipid metabolisms and insulin binding in the adipose tissue of C57BL/6J-ob/ob and -+/? mice.
Chang AY; Wyse BM; Gilchrist BJ
Diabetes; 1983 Sep; 32(9):839-45. PubMed ID: 6354791
[TBL] [Abstract][Full Text] [Related]
31. Troglitazone prevents hyperglycemia-induced but not glucosamine-induced insulin resistance.
Miles PD; Higo K; Romeo OM; Lee MK; Rafaat K; Olefsky JM
Diabetes; 1998 Mar; 47(3):395-400. PubMed ID: 9519745
[TBL] [Abstract][Full Text] [Related]
32. Role of skeletal muscle in thiazolidinedione insulin sensitizer (PPARgamma agonist) action.
Zierath JR; Ryder JW; Doebber T; Woods J; Wu M; Ventre J; Li Z; McCrary C; Berger J; Zhang B; Moller DE
Endocrinology; 1998 Dec; 139(12):5034-41. PubMed ID: 9832442
[TBL] [Abstract][Full Text] [Related]
33. Peroxisome proliferator-activated receptor (PPAR)-alpha activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats: comparison with PPAR-gamma activation.
Ye JM; Doyle PJ; Iglesias MA; Watson DG; Cooney GJ; Kraegen EW
Diabetes; 2001 Feb; 50(2):411-7. PubMed ID: 11272155
[TBL] [Abstract][Full Text] [Related]
34. Effect of diet change on insulin action: difference between muscles and adipocytes.
Maegawa H; Kobayashi M; Ishibashi O; Takata Y; Shigeta Y
Am J Physiol; 1986 Nov; 251(5 Pt 1):E616-23. PubMed ID: 3535536
[TBL] [Abstract][Full Text] [Related]
35. Effect of pioglitazone on insulin receptors of skeletal muscles from high-fat-fed rats.
Iwanishi M; Kobayashi M
Metabolism; 1993 Aug; 42(8):1017-21. PubMed ID: 8345805
[TBL] [Abstract][Full Text] [Related]
36. Heterogeneity of insulin action in individual muscles in vivo: euglycemic clamp studies in rats.
James DE; Jenkins AB; Kraegen EW
Am J Physiol; 1985 May; 248(5 Pt 1):E567-74. PubMed ID: 3887942
[TBL] [Abstract][Full Text] [Related]
37. Prevention of skeletal muscle insulin resistance by dietary cod protein in high fat-fed rats.
Lavigne C; Tremblay F; Asselin G; Jacques H; Marette A
Am J Physiol Endocrinol Metab; 2001 Jul; 281(1):E62-71. PubMed ID: 11404223
[TBL] [Abstract][Full Text] [Related]
38. Insulin resistance with enhanced insulin signaling in high-salt diet-fed rats.
Ogihara T; Asano T; Ando K; Chiba Y; Sekine N; Sakoda H; Anai M; Onishi Y; Fujishiro M; Ono H; Shojima N; Inukai K; Fukushima Y; Kikuchi M; Fujita T
Diabetes; 2001 Mar; 50(3):573-83. PubMed ID: 11246877
[TBL] [Abstract][Full Text] [Related]
39. Malonyl coenzyme A and adiposity in the Dahl salt-sensitive rat: effects of pioglitazone.
Kurowski TG; Saha AK; Cunningham BA; Holbert RI; Colca JR; Corkey BE; Ruderman NB
Metabolism; 1996 Apr; 45(4):519-25. PubMed ID: 8609842
[TBL] [Abstract][Full Text] [Related]
40. In vivo dose response curves of insulin action in heart: anomalous effects at high insulin doses.
James DE; Burleigh KM; Chisholm DJ; Kraegen EW
J Mol Cell Cardiol; 1985 Oct; 17(10):981-5. PubMed ID: 3906139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
